KRISTY CUTSHAW: Open Payments
NPI 1992351175 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,914 in 84 payments from 37 companies in 2025. Trend: 2023 $2,035 · 2024 $1,732 · 2025 $1,914
Food & beverage: $1,736Education: $178
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $197 |
| Janssen Biotech, Inc. | 7 | $180 |
| GENZYME CORPORATION | 5 | $120 |
| Genentech USA, Inc. | 5 | $91 |
| Merck Sharp & Dohme LLC | 4 | $88 |
| Paratek Pharmaceuticals, Inc. | 1 | $83 |
| Astellas Pharma US Inc | 3 | $77 |
| Caris MPI, Inc. | 2 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
Products named: ERLEADA, NUZYRA, JAKAFI, MI CANCER SEEK, NINLARO, RELTONE 200 MG, OPDIVO, Optune Lua (NovoTTF-200T).
Industry payments across TN — which companies pay providers there.
